- Release Date: 16/05/23 08:20
- Summary: First Quarter 2023 Financial Statements and MD&A
- Price Sensitive: Yes
- Download Document 3.31MB
- Forums
- ASX - By Stock
- XAM
- Ann: First Quarter 2023 Financial Statements and MD&A
Ann: First Quarter 2023 Financial Statements and MD&A
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add XAM (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.9¢ |
Change
0.004(7.27%) |
Mkt cap ! $99.52M |
Open | High | Low | Value | Volume |
5.5¢ | 6.1¢ | 5.5¢ | $135.3K | 2.335M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 251724 | 5.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.1¢ | 138081 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 251724 | 0.058 |
3 | 97014 | 0.057 |
1 | 200000 | 0.056 |
3 | 1362152 | 0.055 |
4 | 358001 | 0.054 |
Price($) | Vol. | No. |
---|---|---|
0.061 | 138081 | 2 |
0.063 | 225675 | 3 |
0.064 | 185000 | 2 |
0.065 | 664099 | 3 |
0.066 | 73401 | 1 |
Last trade - 15.58pm 24/09/2024 (20 minute delay) ? |
Featured News
XAM (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online